Enzyme inhibitors
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-02797 | ||
It is a phospholipase C (PLC) inhibitor originally isolated from fungal MT51005. |
||
BBF-02808 | ||
EI-1507-1 is produced by the strain of Streptomyces sp. E-1507. It had weak antibacterial activity, and it inhibited ICE with an IC50 of 0.23 μmol/L. |
||
BBF-02809 | ||
EI-1507-2 is produced by the strain of Streptomyces sp. E-1507. It had weak antibacterial activity, and it inhibited ICE with an IC50 of 0.42 μmol/L. |
||
BBF-02810 | ||
It is produced by the strain of Streptomyces sp. E-1511. EI-1511-3 inhibited recombinant human ICE with an IC50 of 0.09 μmol/L. |
||
BBF-02811 | ||
It is produced by the strain of Streptomyces sp. E-1511. EI-1511-5 inhibited recombinant human ICE with an IC50 of 0.38 μmol/L. |
||
BBF-02812 | ||
It is produced by the strain of Streptomyces sp. E-1625. EI-1625-2 inhibited recombinant human ICE with an IC50 of 0.2 μmol/L. |
||
BBF-02813 | ||
It is originally isolated from Farrowia sp. E-1941. EI-1941-1 inhibited recombinant human ICE with an IC50 of 0.086 μmol/L. It also inhibits elastase and cathepsin. |
||
BBF-02814 | ||
It is originally isolated from Farrowia sp. E-1941. EI-1941-2 inhibited recombinant human ICE with an IC50 of 0.006 μmol/L. It also inhibits elastase and cathepsin. |
||
BBF-02815 | ||
EI-2128-1 is originally isolated from Penicillum sp. E-2128. It selectively inhibited ICE, and the IC50 of recombinant human ICE was 0.59 μmol/L. It also has anti-Gram-positive bacteria such as Bacillus subtilis, Staphylococcus aureus and Enterococcus enterococcus. |
||
BBF-02816 | ||
EI-2346 is originally isolated from Streptomyces sp. E-2346. It selectively inhibited ICE, and the IC50 of recombinant human ICE was 3.9 μmol/L. It also inhibits elastase and cathepsin. |
||
BBF-02825 | ||
F-10748 C1 is originally isolated from Lophodermium sp. SANK 18496. It had inhibitory activity against fungal 1,3-β-glucan synthase with IC50 of 0.2-2 μg/mL. |
||
BBF-02826 | ||
F-10748 C2 is originally isolated from Lophodermium sp. SANK 18496. It had inhibitory activity against fungal 1,3-β-glucan synthase with IC50 of 0.2-2 μg/mL. |
||
BBF-02827 |
F-11334-A1 (171812-79-6) Inquiry |
|
F-11334-A1 is a membrane binding inhibitor of N-SMase originally isolated from Acremonium murorum. Under neutral conditions, the IC50 (μg/mL) of it against rat brain microsomal N-SMase was 7.5. |
||
BBF-02828 |
F-11334-A2 (465539-21-3) Inquiry |
|
F-11334-A2 is a membrane binding inhibitor of N-SMase originally isolated from Acremonium murorum. Under neutral conditions, the IC50 (μg/mL) of it against rat brain microsomal N-SMase was >200. |
||
BBF-02829 |
F-11334-A3 (465539-19-9) Inquiry |
|
F-11334-A3 is a membrane binding inhibitor of N-SMase originally isolated from Acremonium murorum. Under neutral conditions, the IC50 (μg/mL) of it against rat brain microsomal N-SMase was >200. |
||
BBF-02830 | ||
F-11334-B1 is a membrane binding inhibitor of N-SMase originally isolated from Acremonium murorum. Under neutral conditions, the IC50 (μg/mL) of it against rat brain microsomal N-SMase was 3.6. |
||
BBF-02831 | ||
F-11334-B2 is a membrane binding inhibitor of N-SMase originally isolated from Acremonium murorum. Under neutral conditions, the IC50 (μg/mL) of it against rat brain microsomal N-SMase was 3.2. |
||
BBF-02832 | ||
It is produced by the strain of Trichopezizella barbata SANK 25395. F-12509A has competitive inhibitory activity against sphingosine kinase, and the Ki value is 18μmol/L. |
||
BBF-02833 | ||
It is produced by the strain of Penicillum sp. F13459. F13459 had inhibitory activity against inosine 5'-phosphate dehydrogenase and it can inhibit the synthesis of Newcastle disease virus (NDV) hemagglutinin (HA) at 25 μg/mL. |
||
BBF-02854 |
Salfredin A3 (139542-53-3) Inquiry |
|
It is an aldose reductase inhibitor produced by the strain of Crucibulum sp. RF-3817. |